Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy

Lorenzo G R Romano, Lize F D van Vulpen, Paul L den Exter, Floor C J I Heubel-Moenen, Helene L Hooijmeijer, Michiel Coppens, Karin Fijnvandraat, Saskia E M Schols, Paula F Ypma, Cees Smit, Mariëtte H E Driessens, Frits R Rosendaal, Johanna G van der Bom, Samantha C Gouw, Marieke J H A Kruip*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

12 Downloads (Pure)


Background: Desmopressin increases plasma factor VIII and von Willebrand factor levels in persons with nonsevere hemophilia A. Patients’ perspectives on desmopressin are relevant to increase and optimize its suboptimal use. However, patients’ views on desmopressin are not reported. Objectives: To evaluate the perspectives of persons with nonsevere hemophilia A on desmopressin use, barriers for its use, side effects, and their knowledge about desmopressin's efficacy and side effects. Methods: Persons with nonsevere hemophilia A were included in a cross-sectional, national, multicenter study. Questionnaires were filled out by adult patients and children aged ≥12 years themselves. Caretakers filled out questionnaires for children aged <12 years. Results: In total, 706 persons with nonsevere hemophilia A were included (544 mild, 162 moderate, [age range, 0–88 years]). Of 508 patients, 234 (50%) patients reported previous desmopressin use. Desmopressin was considered as at least moderately effective in 171 of 187 (90%) patients. Intranasal administration was the modality of choice for 138 of 182 (76%) patients. Flushing was the most reported side effect in 54 of 206 (26%) adults and 7 of 22 (32%) children. The most frequently reported advantage and disadvantage were the convenience of intranasal, out-of-hospital administration by 56% (126/227) and side effects in 18% (41/227), respectively. Patients’ self-perceived knowledge was unsatisfactory or unknown in 28% (63/225). Conclusion: Overall, desmopressin was most often used intranasally and considered effective, with flushing as the most common side effect. The most mentioned advantage was the convenience of intranasal administration and disadvantage was side effects. More information and education on desmopressin could answer unmet needs in patients with current or future desmopressin treatment.

Original languageEnglish
Article number100281
Pages (from-to)1-8
JournalResearch and practice in thrombosis and haemostasis
Issue number5
Publication statusPublished - Jul 2023


  • hemophilia A
  • advantages
  • patient perspective
  • side effects
  • survey
  • desmopressin


Dive into the research topics of 'Desmopressin in nonsevere hemophilia A: patient perspectives on use and efficacy'. Together they form a unique fingerprint.

Cite this